Durgun Cemalettin
General Surgery, Memorial Dicle Hospital, Diyarbakır, TUR.
Cureus. 2023 May 17;15(5):e39130. doi: 10.7759/cureus.39130. eCollection 2023 May.
Introduction Fine needle aspiration biopsy (FNAB) is an effective method used in the differential diagnosis of thyroid nodules. The Bethesda system has contributed to the determination of clinical approaches by bringing standardization to cytopathology reporting. However, the rate of cytological-histological incompatibility varies between 10% and 30%. Results differ according to clinics in the literature. These results create a need to reevaluate the efficacy and safety of fine needle aspiration biopsy. In this study, we aimed to evaluate the diagnostic accuracy of FNAB of thyroid nodules by correlating the cytopathology results of FNAB with the results of postoperative histopathology. Methods In this retrospective study, thyroid FNAB results and postoperative histopathology results of patients who underwent thyroidectomy operations in our clinic between January 2018 and December 2021 were compared. Accuracy, sensitivity (Sn), specificity (Sp), positive predictive value (PPV), negative predictive value (NPV), false positive rate (FPR), and false negative rate (FNR) were calculated. Cases with nondiagnostic FNAB results were excluded from the calculations. FNAB results with a follicular neoplasm/suspicious for a follicular neoplasm (FN/SFN) and suspicious for malignancy were included in the malignant group. Results A total of 304 patients were included in the study. The male/female ratio was 1:3.3. As a result of the study, malignancy was detected histopathologically in 47 (15.46%) patients. The commonest malignancy detected was papillary carcinoma. According to the Bethesda system, the results were evaluated in six categories. The incidence of malignancy in the Bethesda categories were 0%, 4%, 40%, 69.2%, 100%, and 100%, respectively. Accordingly, the specificity and sensitivity of FNAB for detecting malignancy were 98.7% and 66.6%, respectively. The accuracy was 93.5%. The false positive rate, false negative rate, positive predictive value, and negative predictive value were 1.20%, 33.3%, 91.4%, and 93.8%, respectively. Conclusion Thyroid FNAB is an effective method used with satisfactory reliability in the differential diagnosis of malignancies of thyroid nodules. Still, it has some limitations. This article demonstrates higher rates of malignancy in Bethesda categories III and IV. Therefore, clinical approaches are gaining importance in these categories.
引言 细针穿刺活检(FNAB)是用于甲状腺结节鉴别诊断的一种有效方法。贝塞斯达系统通过使细胞病理学报告标准化,为临床方法的确定做出了贡献。然而,细胞组织学不匹配率在10%至30%之间。文献中的结果因临床机构而异。这些结果使得有必要重新评估细针穿刺活检的有效性和安全性。在本研究中,我们旨在通过将FNAB的细胞病理学结果与术后组织病理学结果相关联,评估甲状腺结节FNAB的诊断准确性。
方法 在这项回顾性研究中,比较了2018年1月至2021年12月期间在我们诊所接受甲状腺切除术的患者的甲状腺FNAB结果和术后组织病理学结果。计算了准确性、敏感性(Sn)、特异性(Sp)、阳性预测值(PPV)、阴性预测值(NPV)、假阳性率(FPR)和假阴性率(FNR)。FNAB结果为非诊断性的病例被排除在计算之外。FNAB结果为滤泡性肿瘤/可疑滤泡性肿瘤(FN/SFN)和可疑恶性的病例被纳入恶性组。
结果 共有304例患者纳入研究。男女比例为1:3.3。研究结果显示,47例(15.46%)患者经组织病理学检测为恶性。最常见的恶性肿瘤是乳头状癌。根据贝塞斯达系统,结果分为六类进行评估。贝塞斯达分类中的恶性发生率分别为0%、4%、40%、69.2%、100%和100%。据此,FNAB检测恶性肿瘤的特异性和敏感性分别为98.7%和66.6%。准确性为93.5%。假阳性率、假阴性率、阳性预测值和阴性预测值分别为1.20%、33.3%、91.4%和93.8%。
结论 甲状腺FNAB是甲状腺结节恶性肿瘤鉴别诊断中一种可靠性令人满意的有效方法。不过,它仍有一些局限性。本文显示贝塞斯达分类III和IV中的恶性率较高。因此,这些分类中的临床方法正变得越来越重要。